Abstract ---3-Alkyl-5-phenyl-3H- [1, 2, 3] triazolo [4,5-d]pyrimidin-7(6H)-ones were prepared by nitrosative cyclization of the appropriate 5,6-diamino-2-phenylpyrimidin-4(3H)-ones with nitrous acid and were subjected to regioselective alkylation with several alkylating agents in aprotic solvent at different temperature. Simultaneous 6-N-and 7-O-alkylations were observed and the regioselectivity varied remarkably with size and shape of the alkylating agents as well as with the reaction temperature. Similar N-and O-alkylations as well as selectivity were also observed in the case of 2-phenyl-9-propyl-9H-purin-6(1H)-one. Some of the synthesized compounds showed moderate antiviral and antitumor activities.
Introduction
The fused pyrimidine derivatives such as naturally occurring purine bases and their analogues have been focused of great interest over many years by reason of their diversified biological activities. [1] [2] [3] [4] [5] Particular interests are the structural modification of purine bases as well as introduction of different functional groups into these bases in the view of searching potential antineoplastic and antiviral agents. Introduction of different functional groups, e.g., amino, oxo, thioxo, alkylthio, alkyl/aryl groups, into purine bases at different positions has been assessed for potency and selectivity for the biological system. 2,6-11 6-Chloro, thioxo, alkylthio, amino purine derivatives as well as 9-substituted purine derivatives have been reported for good antitumor and antiviral activities. 2, [6] [7] 11 A few effective and clinically applicable antineoplastic and antiviral agents have been reported so far. Therefore, continuous efforts have been conducted for the synthesis of purines and their analogues for searching the effective biological agents. To be biologically active for any compound needs some active sites to interact with DNA or RNA. A minor modification of a biologically active compound can greatly alter its potentiality. Thus, more modifications of biologically active purine derivatives may lead to achieve the highly expected effective antiviral and antitumor drugs. Hence, our laboratory has designed the program for the synthesis of fused pyrimidines, [12] [13] [14] [15] [16] [17] [18] [19] . Initially, it was expected that the chlorination might take place only at the 7-position, but actually, the alcoholic hydroxyl group of both compounds was also replaced by a chlorine to afford the corresponding 7-chloro-3-(2-chloroethyl)-6 and 7-chloro-3-(3-chloropropyl)- [4,5-d ]pyrimidine 7 in 87% and 84% yields, respectively. The absence of the alcoholic absorption band in the IR spectra as well as the broad singlet signal attributable to the alcoholic OH proton in the 1 H NMR spectra of these two derivatives 6 and 7 showed the substitution of hydroxyl group to chlorine. When the dichlorinated derivatives 6 and 7 were treated with sodium methoxide in methanol at room temperature, the nucleophilic substitution took place only at the 7-position to give the corresponding 3-(2-chloroethyl)-7-methoxy-8 and 3-(3-chloropropyl)-7-methoxy-5-phenyl-3H- [1, 2, 3] triazolo [4,5-d ]pyrimidine 9 in 81% and 88% yields, respectively. 1 H NMR spectra of these two methoxy derivatives showed only one singlet signal (δ 4.38) attributable to the 7-O-methyl protons, which was consistent with the other 7-O-methyl derivatives (δ 4.37-4.40 for 4a-g). Besides, the physical and spectral data of 3-(2-hydroxyethyl)-7-methoxy 4f and 3-(3-hydroxypropyl)-7-methoxy-5-phenyl-3H- [1, 2, 3] triazolo- [4,5-d] pyrimidine 4g obtained by methylation of 2f and 2g were different from that of 8 and 9, respectively. Hence, it is obvious that the replacement of chlorine by methoxy group took place selectively at the 7-position without at the side chain of 6 and 7.
To examine the effect of size and shape of the alkylating agents on the O-and N-alkylations, compound 2b was chosen as the model compound. The alkylation of 2b with dimethyl sulfate, ethyl iodide or benzyl bromide in the presence of anhydrous potassium carbonate in N,N-dimethylformamide at room temperature afforded the 7-O-alkylated derivatives 4b, 4ba, 4bb as the major products (61-66% yields) along with the 6-N-alkylated derivatives 3b, 3ba, 3bb
(10-17% yields) (Scheme 4). Even the methylation as well as ethylation of 2b with dimethyl sulfate and ethyl iodide at boiling temperature led to the 7-O-methyl 4b (39% yield) and 7-O-ethyl 4ba (41% yield) derivatives as the major products accompanied with 6-N-methyl 3b (16% yield) and 6-N-ethyl 3ba (18% yield) derivatives, respectively. In the case of benzylation of 2b at boiling temperature two regoisomers 3bb and 4bb were obtained almost in equal quantity.
Hence, it is apparent that the 7-O-alkylation favored preference over the 6-N-alkylation for bulkier alkylating agents due to the steric interaction of the alkylating agents with the phenyl group at the 5-position. That is, the energy produced at boiling temperature in N,N-dimethylformamide is not sufficient enough to overcome the steric interaction force for bulkier alkylating agents to give only the more stable 6-N-alkyl derivatives. For confirmation of the 7-O-alkylation, the compound 4ba was also prepared by treating 5b with sodium ethoxide in ethanol at room temperature, which was identical in all respects with the 7-ethoxy derivative obtained by ethylation of 2b. IR, 1 H NMR and UV spectra as well as microanalyses for these 6-N-alkylated and 7-O-alkylated derivatives were also quite satisfactory to assign and differentiate the regioisomers as discussed for 6-N-methyl 3a-g and 7-O-methyl 4a-g regioisomers.
On the other hand, the similar regioselective N-and O-alkylation was also observed in the alkylation on purine ring.
2-Phenyl-9-propyl-9H-purin-6(1H)-one 10 was prepared by treating free 5,6-diaminopyrimidine derivative 1b with 85% formic acid in order to observe the alkyaltion position on the pyrimidine ring of it (Scheme 5). The methylation of 10 with 1 equiv methyl iodide in the presence of anhydrous potassium carbonate in N,N-dimethylformamide at 0 °C gave the 1-N-methyl 11a and 6-O-methyl isomer 11b in 26% and 45% yields, respectively. The same methylation with excess methyl iodide at room temperature gave 11b and 6,9-dihydro-1,7-dimethyl-6-oxo-2-phenyl-9-propyl-1H-purin-7-ium hydroxide 12 in 44% and 30% yields, respectively. Similar methylation of 10 with 1 equiv dimethyl sulfate at room temperature gave only 11b in 76% yield. Therefore, it is obvious that the O-methylation of 2-phenylhypoxanthine 10 takes place more preferentially over the N-methylation compared with that of 2-phenyl-8-axahypoxanthine 2.
Besides, the 1,9-disubstitted hypoxanthine 11a forms the 1,7,9-trisubstituted quaternary salt 12 with excess alkylating agent. Among the tested compounds, 5a and 5c were more potential (>0.8 µg/mL) against both viruses. Compound 2e showed its activity at the concentration >4 µg/mL. Some compounds, e.g., 2a,d, 3e,bb, 4d, 5b,d, 6, and 8, showed activity against both herpes viruses at the concentration >20 µg/mL and some did not exhibit any activity up to 100 µg/mL.
7-Chloro derivatives are comparatively more active than 6-N-alkyl or 7-O-alkyl derivatives.
Antitumor activity
The modified 32 against CCRF-HSB-2 and KB cells at the concentration 17.5 µg/mL and 11.0 µg/mL, respectively, while 6-N-methyl-3-octyl derivative 3e exhibited about similar activity (25.9 µg/mL and 29.0 µg/mL) against both cells. Other compounds were too low toxic to exhibit potential activity. Thus, it is apparent that the presence of electronegative chlorine atom at the 7-position is significant for antitumor activity. Besides, among the alkyl groups at the 9-position, octyl group is responsible for increased activity due to its hydrophobic character. 6-N-Alkyl and 7-O-alkyl groups do not enhance antitumor activity.
Conclusion
Thus, this can be concluded that the NH proton on the pyrimidine ring of 5-phenyl-3H- 
Experimental

General
Mps were determined on a Yanagimoto micro-melting point hot stage apparatus and were uncorrected. IR spectra were obtained using a JASCO FT/IR-200 spectrophotometer in Nujol mulls. UV spectra were recorded with a Beckman DU-68 spectrophotometer in ethanol. IR and UV absorption values in italic refer to wave numbers and wave length respectively, at which shoulders or inflexions occur in the absorption. 1 H NMR spectra were measured using a VXR 300
MHz spectrometer and chemical shift values were expressed in δ values (ppm) relative to TMS as an internal standard. 
General procedure for the synthesis of 6-alkylamino-5-amino-2-phenylpyrimidin-4(3H)-one hemisulfates (1a-g)
A mixture of an appropriate 6-alkylamino-5-nitroso-2-phenylpyrimidin-4(3H)-ones (8.0 mmol), acetic acid (5 mL), water (50 mL), and methanol (50 mL) was heated to ca. 60 °C and to it was added Na 2 S 2 O 4 (25-32 mmol) by portions with stirring. Then, the mixture was heated at 70 °C for 0.5-1.0 h. After the reaction was complete, the solution was concentrated to ca. 20 mL and to it was added water (25 mL). Upon keeping the mixture at room temperature (rt) for several hours, the solid deposited was collected by filtration to give the corresponding 5,6-diamino hemisulfate derivatives 1a-g as pale yellow powdery crystals. For analysis a portion of these products were recrystallized from dilute H 2 SO 4 except 1e, which was recrystallized from a mixture of ethanol and dilute H 2 SO 4 .
5-Amino-6-ethylamino-2-phenylpyrimidin-4(3H)-one hemisulfate (1a)
Yield 1 
5-Amino-6-(2-hydroxyethylamino)-2-phenylpyrimidin-4(3H)-one hemisulfate (1f)
General procedure for the synthesis of 3-alkyl-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones (2a-g)
A cooled solution of NaNO 2 (10.0 mmol) in water (5 mL) on ice was added to a solution of an appropriate 1a-g 
3-Isobutyl-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one (2d)
General procedure for the methylation of 2a-g with methyl iodide
At room temperature (A)
A mixture of an appropriate 2a-g (2.5 mmol), anhydrous K 2 CO 3 (5.0 mmol) and MeI (7.5 mmol) in dry DMF (25 mL) was stirred at rt for 5-6 h. Then, the solution was evaporated to dryness in vacuo and water (15 mL) was added to the residue. The solid deposited was collected by filtration and washed with water. The two regioisomers cropped were separated by column chromatography on silica gel using an appropriate mixture of n-hexane and EtOAc as eluting solvent to afford the corresponding 7-methoxy 4a-g and 6-methyl derivatives 3a-g as the first and second fraction, respectively.
3-Ethyl-6-methyl-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one (3a)
Colorless needles; yield 0. 
3-Isopropyl-6-methyl-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one (3c)
Colorless prisms; yield 0.30 g (1.10 mmol, 44%); mp 200-201 °C (n-hexane/EtOAc); R f 0.51 (n-hexane/EtOAc, 
3-Isobutyl-6-methyl-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one (3d)
Colorless needles; yield 0.35 g (1.23 mmol, 49%); mp 159-160 °C (n-hexane/EtOAc); R f 0.52 (n-hexane/EtOAc, 
3-(2-Hydroxyethyl)-6-methyl-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one (3f)
Colorless powdery crystals; yield 0. 
3-(3-Hydroxypropyl)-6-methyl-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one (3g)
Pale yellow powdery crystals; yield 0. 
3-Ethyl-7-methoxy-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (4a)
7-Methoxy-5-phenyl-3-propyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (4b)
Colorless needles; yield 0.22 g (0.80 mmol, 32%); mp 119-120 °C (n-octane/EtOAc); R f 0.35 (n-hexane/EtOAc, 
3-(3-Hydroxypropyl)-7-methoxy-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (4g)
At boiling temperature (B)
A mixture of an appropriate 2a-g (1.8 mmol), anhydrous K 2 CO 3 (3.6 mmol) and MeI (7.2 mmol) in dry DMF (20 mL) was refluxed for 1 h. Then, the solution was evaporated to dryness in vacuo and water (12 mL) was added to the residue. The solid deposited was filtered, washed with water, and recrystallized from an appropriate organic solvent to give the corresponding 6-N-methyl derivatives 3a-g in 81%, 76%, 73%, 81%, 71%, 76% and 74% yields, respectively.
Methylation of 2b with methyl iodide in the presence of NaH
A mixture of 2b (0.4 g, 1.57 mmol), NaH (0.12 g, 5.0 mmol), and MeI (0.61 g, 4.3 mmol) in dry DMF (25 mL) was stirred at 0 °C for 7 h. After the usual work-up like above general method as described in Section 4.4.1., the compounds 3b and 4b were obtained in 52% and 28% yields, respectively.
General procedure for the chlorination of 2a-d
To a cooled mixture of an appropriate 2a-d (3.0 mmol) and phosphoryl chloride (POCl 3 ) (12 mL) was added N,N-dimethylaniline (0.7 mL) with stirring and the reaction mixture was refluxed gently for 3 h. Then, the excess POCl 3 was evaporated in vacuo and the residue was treated with cracked ice (20 g). Thus, the solid deposited was filtered, washed well with water and dried to give the corresponding 7-chloro-derivatives 5a-d. 
General procedure (C) for the synthesis of 4a-d from 5a-d
Sodium (0.05 g, 2.17 mmol) was dissolved in absolute methanol (30 mL) and to it was added an appropriate 5a-d
(1.0 mmol). The resulting solution was stirred at rt for 1-2 h. Then, the solution was evaporated in vacuo to dryness and water (10 mL) was added to the residue. Thus, the solid deposited was filtered, washed with water, and recrystallized from a mixture of n-octane and EtOAc to afford the corresponding products 4a-d in 91%, 94%, 93% and 87% yields, respectively.
7-Chloro-3-(2-chloroethyl)-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (6)
The compound 6 was prepared from 2f (0.50 g, 1.94 mmol) according to the general procedure for chlorination of 
7-Chloro-3-(3-chloropropyl)-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (7)
The compound 7 was prepared from 2g (0.60 g, 2.21 mmol) in the similar way to 6 as colorless prisms; yield 0.57 g (84%); mp 120-121 °C (n-hexane); R f 0.30 (n-hexane/EtOAc 
3-(2-Chloroethyl)-7-methoxy-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (8)
To a solution of sodium methoxide (from 0.03 g of Na, 1.30 mmol) in methanol (25 mL) was added 6 (0.15 g, 0.51 mmol) and the mixture was stirred at rt for 1 h. Then, the solvent was removed in vacuo and water (10 mL) was added to the residue. Thus, the solid deposited was collected by filtration, washed with water to give the product 8 as pale yellow needles; yield 0.12 g (81%); mp 182-183 °C (n-octane/EtOAc); R f 0.16 (n-hexane/EtOAc 
3-(3-Chloropropyl)-7-methoxy-5-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (9)
The compound 9 was prepared from 7 (0. mmol) in dry DMF (25 mL) was stirred at rt for 8 h. After the usual work-up like the general method as described in Section 4.4.1., the compounds 3b and 4b were obtained in 17% and 61% yields, respectively.
At boiling temperature
The above methylation of 2b with dimethyl sulfate at boiling temperature for 3 h gave 3b and 4b in 16% and 39% yields, respectively. 
The above ethylation of 2b with little more excess ethyl iodide (ca. 5 equiv) at boiling temperature for 4 h gave 3ba
and 4ba in 18% and 41% yields, respectively.
Preparation of 4ba from 5b
To a solution of sodium ethoxide (from 0.02 g of Na, 0.87 mmol) in absolute ethanol (20 mL) was added 5b (0.11 g, 0.40 mmol) and the solution was stirred at rt for 1 h. The solvent was removed in vacuo and water (10 mL) was added to the residue. Thus, the solid deposited was collected by filtration, washed with water to give 4ba (0.09 g, 79%), which was identical in all respects with authentic sample prepared by another method. 
At boiling temperature
The above benzylation of 2b with benzyl bromide at boiling temperature for 1 h gave 3bb and 4bb in 37% and 35% yields, respectively.
Preparation of 2-phenyl-9-propyl-9H-purin-6(1H)-one (10)
A solution of free 5,6-diaminopyrimidine derivative 1b (1.0 g, 4.09 mmol) in 85% aqueous formic acid (15 mL) was heated under reflux for overnight. Then, the solution was concentrated to ca. 2 mL and to it was added water (15 mL DMF (20 mL) was stirred at rt for 1 day. Then, the solution was evaporated to dryness in vacuo and water (10 mL) was added to the residue. The products were extracted with CH 2 Cl 2 and the extract was dried over anhydrous MgSO 4 .
Solvent was removed in vacuo and the residue was recrystallized from n-hexane to give 11b (0.24 g, 76%).
With excess MeI at room temperature
A mixture of 10 (0. 
